Global Perspectives in Current and Future Management of CRC

CRC-specific discussions on therapeutic advances and their application in clinical decision-making

January 20, 2024


Tanios S. Bekaii-Saab, MD, FACP

Mayo Clinic, Phoenix, AZ, USA

Faculty Members

Zev Wainberg, MD
University of California, Los Angeles, CA, USA

Mariano Dioca, MD
Instituto de Oncologia Ángel H. Roffo, Buenos Aires, Argentina

Kristen Ciombor, MD
Vanderbilt University, Nashville, TN, USA

Michael Overman, MD
MD Anderson Cancer Center, Houston, TX, USA

Aparna Parikh, MD
Tucker Gosnell Center for Gastrointestinal Cancers, Boston, MA, USA

Julien Taieb, MD, PhD
Georges Pompidou European Hospital, Paris, France

Thierry André, MD
Sorbonne Université, Paris, France

Sample Report

Start discovering the insights

View Report


  • Metastatic CRC – Targeted Therapies
  • Metastatic CRC – Immunotherapy
  • Predictive and Prognostic Biomarkers in CRC
  • Rectal Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.